The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...

Biological response modifiers are a class of drugs used to treat rheumatoid arthritis (RA). Your doctor may suggest that you start right after your diagnosis, which can help address joint damage.

Patients with both RA and metabolic syndrome demonstrated lower response rates to TNF inhibitor and non-TNF inhibitor therapies.

Research reveals a higher cancer risk for rheumatoid arthritis patients using certain biologics, emphasizing the need for ...